Prognostic and Therapeutic Utility of Variably Expressed Cell Surface Receptors in Osteosarcoma
Background. Six cell surface receptors, human epidermal growth factor receptor-2 (Her-2), platelet-derived growth factor receptor-β (PDGFR-β), insulin-like growth factor-1 receptor (IGF-1R), insulin receptor (IR), c-Met, and vascular endothelial growth factor receptor-3 (VEGFR-3), previously demonst...
Main Authors: | Yoav Zvi, Elif Ugur, Brian Batko, Jonathan Gill, Michael Roth, Richard Gorlick, David Hall, Janet Tingling, Donald A. Barkauskas, Jinghang Zhang, Rui Yang, Bang H. Hoang, David S. Geller |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | Sarcoma |
Online Access: | http://dx.doi.org/10.1155/2021/8324348 |
Similar Items
-
The effect of bone morphogenetic protein-2 on osteosarcoma metastasis.
by: Jonathan Gill, et al.
Published: (2017-01-01) -
Upfront surgical resection for primary bone tumors: rationale and potential benefits
by: Yoav S. Zvi, et al.
Published: (2020-02-01) -
sCLU as prognostic biomarker and therapeutic target in osteosarcoma
by: Jinfeng Ma, et al.
Published: (2019-01-01) -
Myc is a prognostic biomarker and potential therapeutic target in osteosarcoma
by: Wenlong Feng, et al.
Published: (2020-05-01) -
Insulin-like growth factor 1 receptor and response to anti-IGF1R antibody therapy in osteosarcoma.
by: Yu Cao, et al.
Published: (2014-01-01)